Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

The Effect of Calisthenic Exercise on Aerobic Capacity, Muscle Strength and Quality of Life in Hemodialysis Patients: a Single-blind Placebo-controlled Randomized Trial

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT05166486
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:39:10.825971+00:00
Published At
2023-05-10T00:00:00+00:00
Record Updated At
2023-05-10
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Physical Activity", "Patient", "Quality of Life", "Hemodialysis"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2023-05-10"
protocolSection.identificationModule.nctId
"NCT05166486"
protocolSection.identificationModule.officialTitle
"The Effect of Calisthenic Exercise on Aerobic Capacity, Muscle Strength and Quality of Life in Hemodialysis Patients: a Single-blind Placebo-controlled Randomized Trial"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["NA"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Physical Activity (protocolSection.conditionsModule.conditions)
  • Patient (protocolSection.conditionsModule.conditions)
  • Quality of Life (protocolSection.conditionsModule.conditions)
  • Hemodialysis (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.